Page last updated: 2024-11-06

prednisolone and Adolescent Obesity

prednisolone has been researched along with Adolescent Obesity in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Treatment of children with congenital adrenal hyperplasia (CAH) with corticosteroids (CS) may increase the risk for developing different components of metabolic syndrome (MetS)."1.72Growth and Metabolic Syndrome (MetS) criteria in young children with classic Congenital Adrenal Hyperplasia (CAH) treated with corticosteroids (CS). ( Abdel Meguid, SE; Abougabal, AMS; Ahmed, S; De Sanctis, V; Hamed, N; Hassan, M; Ramadan, MAEF; Soliman, AT, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdel Meguid, SE1
Soliman, AT1
De Sanctis, V1
Abougabal, AMS1
Ramadan, MAEF1
Hassan, M1
Hamed, N1
Ahmed, S1

Other Studies

1 other study available for prednisolone and Adolescent Obesity

ArticleYear
Growth and Metabolic Syndrome (MetS) criteria in young children with classic Congenital Adrenal Hyperplasia (CAH) treated with corticosteroids (CS).
    Acta bio-medica : Atenei Parmensis, 2022, 10-26, Volume: 93, Issue:5

    Topics: Adrenal Hyperplasia, Congenital; Carotid Intima-Media Thickness; Child; Child, Preschool; Cholestero

2022